Next, we sought to understand these communities by performing GSEA, and discovered that 2 7 0 one of these communities (mHYP1) was significantly enriched (FDR<0.05) for gene sets associated chromosome 3 monosomy and mHYP4 may be by disomy, may be defined by that particular 2 7 7 phenotype as opposed to a coherent transcriptomic pattern. Patient prognostic differences between uveal melanoma subtype communities 2 8 0
Since more than 50% uveal melanoma patients undergo metastasis [28] , we assessed the 2 8 1 metastasis-free prognosis of the uveal melanoma subtype communities using the GSE22138 [28] 2 8 2 data set. Among the two highly frequent communities, mHYP2 (37%) showed significantly poorest 2 8 3 metastasis-free prognosis, whereas mHYP5 (28%) showed better prognosis. Both mHYP4 (20%) 2 8 4 and mHYP1 (11%) communities showed intermediate prognosis (Figure 6A ). Due to the low frequency of some of these communities in this dataset (5% mHYP3, 11% 2 8 8 mHYP1), we sought to validate them in an independent dataset consisting of 58 patients with uveal 2 8 9 melanoma (GSE44295). Patients were assigned to subtypes based on the correlation of their gene 2 9 0 expression profile with the prediction analysis of microarrays (PAM) [29] centroids of each 2 9 1 community. In the validation cohort, 31% of patients were assigned to the mHYP1 (immune-2 9 2 enriched) group, 19% mHYP2 (monosomy-enriched), 14% mHYP3 (neural-enriched), 5% mHYP4 2 9 3
(undetermined) and 31% mHYP5 (disomy/partial monosomy-enriched). In terms of prognosis, 2 9 4 these groups showed statistically significant differential metastasis-free survival (p = 0.00747; 2 9 5 Figure 6B ). Analogous to the previous dataset, mHYP2 and mHYP5 communities showed poor and has poor overall survival and 57% of the mHYP3 samples were undergoing metastasis ( Figure 6B ).
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Overall, this identifies and validates novel uveal melanoma subtype communities and their 3 0 5 prognostic significance. in the mHYP1 community (immune-enriched; FDR < 0.001; Figure 6C ) and mHYP2 (monosomy; 3 1 5 FDR = 0.27; Figure 6D ) groups, respectively, whereas, unexpectedly, the class 1 signature was not should be applied to the same dataset, and their results compared and reconciled. Our polyCluster 3 2 5
tool provides a straightforward interface to cluster datasets using multiple algorithms, provides 3 2 6
statistics on the quality of each clustering, and allows the user to fully understand how each result is 3 2 7
related through multiple reconciliations. The demonstration that some low-frequency clusters -
which may be lost or discarded as outliers if only one algorithm is applied -are consistently 3 2 9
identified across algorithms lends credence to their validity, and here such communities were 3 3 0 additionally validated in an independent dataset. Thus, the reconciliation of multiple clustering 3 3 1 results enables finer stratification of patients' molecular profiles enabling more focused biological 3 3 2 profiling. The breast cancer dataset [22] consists of 118 gene expression profiles generated from expression profiles from enucleation specimens, with metastasis-free survival information. Finding the optimal number of clusters 3 4 5
It is a not optimal for each of the above clustering methods to find local solutions which 3 4 6 depend on the initial conditions, rather than robust clusterings that are stable over various input inspected in order to determine the optimal k. Determining the optimal k from visual inspection 3 5 2 alone is subjective, and so quantification of the consensus clustering is required. Here, the Silhouette width was calculated and plotted using the silhouette function from the R package cluster publicly available on GitHub at https://github.com/syspremed/polyClustR. GSE22138 and GSE44295 (uveal melanoma). A. Sadanandam has ownership interest (including patents) as a patent inventor for a patent entitled analysed the results. GN helped with the statistical methods and oversaw the data analysis. AS 3 9 7
conceived the idea, interpreted the results and wrote the manuscript. References 
